# Flyte

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/flyte

- Industry: Medical Devices & Equipment
- Headquarters: Eagan, US
- Website: www.flytetherapy.com/
- Total disclosed funding: $4.9M
- Latest round: Seed (Apr 22, 2024)
- Investors on record: 6

## About

Established in 2016 and based in Minnesota, US, Pelvital USA, Inc. trading under the name Flyte operates as a healthcare company that develops medical investigational devices that cures bladder leaks. In April 2024, Flyte raised USD 2.32 million in seed funding led by Boomerang Ventures, with participation from Blue Pacific Fund, Life Science Angels, Inc., Pier 70 Ventures, and Tech Coast Angels.


Flyte offers an at-home intravaginal device designed to treat stress urinary incontinence and strengthen pelvic floor muscles. It also offers an active treatment approach by leveraging mechanotherapy, promoting natural healing responses within pelvic floor muscles. 

The company will use the funding to develop its new product and expand commercialization and market reach.

## Funding rounds

- Seed, Apr 22, 2024, $2.3M — Tech Coast Angels, Life Science Angels, Inc., Boomerang Ventures, Pier 70 Ventures
- Seed, May 2, 2023, $2.6M — Wisconsin Investment Partners, VisionTech Partners, Boomerang Ventures

## Investors

- Wisconsin Investment Partners (https://capitalatlas.ai/funds/wisconsin-investment-partners) — Seed
- VisionTech Partners (https://capitalatlas.ai/funds/visiontech-partners) — Seed
- Boomerang Ventures (https://capitalatlas.ai/funds/boomerang-ventures) — Seed
- Tech Coast Angels — Seed
- Life Science Angels, Inc. — Seed
- Pier 70 Ventures (https://capitalatlas.ai/funds/pier-70-ventures) — Seed